Use of charcoal hemoperfusion and hemodialysis in the treatment of methotrexate toxicosis in a dog

2018 ◽  
Vol 28 (3) ◽  
pp. 269-273 ◽  
Author(s):  
Mariana Pardo ◽  
Travis Lanaux ◽  
Rachel Davy ◽  
Carsten Bandt
1983 ◽  
Vol 13 (5) ◽  
pp. 509-512 ◽  
Author(s):  
Z. H. ENDRE ◽  
G. J. MACDONALD ◽  
J. A. CHARLESWORTH ◽  
L. WOODBRIDGE

1985 ◽  
Vol 78 (5) ◽  
pp. 611-613 ◽  
Author(s):  
JOHN W. ENGSTROM ◽  
JAMES YOUNG ◽  
WILLIAM A. RENNIE ◽  
THOMAS P. KENNEDY

1982 ◽  
Vol 5 (4) ◽  
pp. 243-247 ◽  
Author(s):  
F. Cordopatri ◽  
S. Boncinelli ◽  
M. Marsili ◽  
P. Lorenzi ◽  
L.P. Fabbri ◽  
...  

The coagulation-fibrinolysis system and platelet function were studied in two patients with fulminant hepatic failure undergoing charcoal hemoperfusion with prostacyclin (PGI2) infusion. There was no adverse effect on the purely coagulative side and significant decreases were found only in Factors V and VII. There was a significant increase in platelet count and initially high BTG values decreased to normal. The findings suggest that PGI2 greatly improves the biocompatibility of hemoperfusion devices.


1982 ◽  
Vol 5 (5) ◽  
pp. 315-317 ◽  
Author(s):  
M. Altin ◽  
R.D. Hughes ◽  
R. Williams

Neutrophil adherence to nylon fibre packed in plastic syringes was determined in blood from patients with fulminant hepatic failure, both before and during charcoal hemoperfusion carried out with prostacyclin infusion and resin hemoperfusion without prostacyclin. During charcoal hemoperfusion there was a progressive decrease in neutrophil adherence, reaching the lowest value at 4 h (30.4 ± SE 4.8%). After completion of hemoperfusion the adherence value returned to the preperfusion level (53.0 ± 8.4%). These effects are probably attributable to the PGI2 infusion. No marked changes in neutrophil adherence were observed during resin hemoperfusion.


Sign in / Sign up

Export Citation Format

Share Document